SC 13G Filing

Company

VERTEX PHARMACEUTICALS INC / MA

Filed

April 21, 1997

Accession Number

0000945621-97-000072

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →